Floatz logo

Vrp-Encapsulated Sarna Encoding Il-12

Head Neck Cancer

VLP Therapeuticsgene_therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Head Neck Cancer cohort.

Asset / SponsorPhaseRating
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Natalie Lockney
Phase 3BB
NC 410
NextCure, Inc.
Phase 1/2CC
Nelitolimod
Dynavax Technologies Corporation
Phase 1/2CC

Same molecule, other indications

Vrp-Encapsulated Sarna Encoding Il-12 is also rated in:

head and neck squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
mouth disorderDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →